| NAME | : | Enasidenib |
| BOBOT | : | 473.383 |
| RUMUS | : | C19H17F6N7O |
| THERAPEUTIC INDC | : | Indicated for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) with an isocitrate dehydrogenase-2 (IDH2) mu... |
| CATEGORIES | : | Isocitrate Dehydrogenase 2 Inhibitor |
| STRUCTURE | : |  |